These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19303967)

  • 21. Retinol-binding protein 4 is associated with arterial stiffness in early postmenopausal women.
    Chondrou A; Nigdelis MP; Armeni E; Augoulea A; Rizos D; Kaparos G; Alexandrou A; Goulis DG; Patras R; Aivalioti E; Stamatelopoulos K; Lambrinoudaki IV
    Menopause; 2020 Aug; 27(8):906-912. PubMed ID: 32665530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects.
    Graham TE; Wason CJ; Blüher M; Kahn BB
    Diabetologia; 2007 Apr; 50(4):814-23. PubMed ID: 17294166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinol-binding protein 4 is elevated and is associated with free testosterone and TSH in postmenopausal women.
    Güdücü N; Görmüş U; Kavak ZN; İşçi H; Yiğiter AB; Dünder İ
    J Endocrinol Invest; 2013 Nov; 36(10):831-4. PubMed ID: 23633638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Lee HC; Kim JM
    Metabolism; 2009 Nov; 58(11):1523-9. PubMed ID: 19501863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of retinol binding protein 4 in women with different levels of adiposity and glucose tolerance.
    Comucci EB; Vasques AC; Geloneze B; Calixto AR; Pareja JC; Tambascia MA
    Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):709-14. PubMed ID: 25372579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinol-binding protein 4 in polycystic ovary syndrome--association with steroid hormones and response to pioglitazone treatment.
    Aigner E; Bachofner N; Klein K; De Geyter C; Hohla F; Patsch W; Datz C
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1229-35. PubMed ID: 19158194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation of retinol binding protein 4 with 
metabolic indexes of glucose and 
lipid, bile cholesterol saturation index].
    Wang W; Li N
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 40(6):657-65. PubMed ID: 26164516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum retinol-binding protein 4 levels in polycystic ovary syndrome.
    Lingaiah S; Morin-Papunen L; Piltonen T; Sundström-Poromaa I; Stener-Victorin E; Tapanainen JS
    Endocr Connect; 2019 Jun; 8(6):709-717. PubMed ID: 31051472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4.
    Yagmur E; Weiskirchen R; Gressner AM; Trautwein C; Tacke F
    Diabetes Care; 2007 May; 30(5):1168-72. PubMed ID: 17337499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes.
    Gavi S; Stuart LM; Kelly P; Melendez MM; Mynarcik DC; Gelato MC; McNurlan MA
    J Clin Endocrinol Metab; 2007 May; 92(5):1886-90. PubMed ID: 17299074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum retinol-binding protein 4 is associated with insulin resistance in older women.
    Suh JB; Kim SM; Cho GJ; Choi KM; Han JH; Taek Geun H
    Metabolism; 2010 Jan; 59(1):118-22. PubMed ID: 19766271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Livadas S; Kandarakis SA; Papassotiriou I; Margeli A
    J Endocrinol Invest; 2008 Nov; 31(11):950-5. PubMed ID: 19169049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies.
    Karakas SE; Banaszewska B; Spaczynski RZ; Pawelczyk L; Duleba A
    Gynecol Endocrinol; 2013 May; 29(5):483-7. PubMed ID: 23480783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinol-binding protein 4 (RBP4) and high sensitivity C-reactive protein (hs-CRP) levels in patients with diminished ovarian reserve (DOR): a cross-sectional study.
    Zou W; Wang Z; Xia J; Yang J
    Reprod Biol Endocrinol; 2020 Nov; 18(1):111. PubMed ID: 33198782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinol-binding protein 4, as a negative acute-phase reactant in polycystic ovary syndrome.
    Güdücü N; Görmüş U; Telatar B; Dünde I
    Minerva Endocrinol; 2014 Dec; 39(4):299-304. PubMed ID: 25371056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women.
    Baron AT; Lafky JM; Suman VJ; Hillman DW; Buenafe MC; Boardman CH; Podratz KC; Perez EA; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1175-85. PubMed ID: 11700266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma Levels of Retinol Binding Protein 4 Relate to Large VLDL and Small LDL Particles in Subjects with and without Type 2 Diabetes.
    Wessel H; Saeed A; Heegsma J; Connelly MA; Faber KN; Dullaart RPF
    J Clin Med; 2019 Oct; 8(11):. PubMed ID: 31717719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.
    Dunaif A; Graf M
    J Clin Invest; 1989 Jan; 83(1):23-9. PubMed ID: 2642919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
    Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.